Envestnet Asset Management Inc Exelixis, Inc. Transaction History
Envestnet Asset Management Inc
- $302 Billion
- Q4 2024
A detailed history of Envestnet Asset Management Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 200,228 shares of EXEL stock, worth $7.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200,228
Previous 170,336
17.55%
Holding current value
$7.74 Million
Previous $4.42 Million
50.84%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding EXEL
# of Institutions
566Shares Held
251MCall Options Held
1.45MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.29 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.14 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$906 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$591 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$441 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.4B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...